Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K Current report
- 3.1 Certificate of Incorporation of Orchestra Biomed Holdings, Inc
- 3.2 Bylaws of Orchestra Biomed Holdings, Inc
- 4.14 Amended and Restated Warrant to Purchase Common Stock of Orchestra Biomed Holdings, Inc
- 10.1 Amended and Restated Registration Rights and Lock-up Agreement, by and Among Health Sciences Acquisitions Corporation 2, Equityholders Thereof and Certain Stockholders of Orchestra Biomed, Inc
- 10.2 Form of Indemnification Agreement of Orchestra Biomed Holdings, Inc
- 10.7 Orchestra Biomed Holdings, Inc. 2023 Equity Incentive Plan
- 10.8 Form of Stock Option Grant Notice and Stock Option Agreement Under the Orchestra Biomed Holdings,inc. 2023 Equity Incentive Plan
- 10.9 Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement Under the Orchestra Biomed Holdings, Inc. 2023 Equity Incentive Plan
- 10.19 Employment Agreement, by and Between Orchestra Biomed Holdings, Inc. and David P. Hochman, Dated January 26, 2023
- 10.20 Employment Agreement, by and Between Orchestra Biomed Holdings, Inc. and Darren R. Sherman, Dated January 26, 2023
- 16.1 Letter from Withumsmith+brown, PC to the Sec, Dated January 31, 2023
- 21.1 List of Subsidiaries
- 99.1 Press Release, Dated January 27, 2023
- 99.2 Unaudited Pro Forma Condensed Combined Financial Information and the Accompanying Notes As of and for the Nine Months Ended September 30, 2022 and for the Year December 31, 2021
- Download Excel data file
- View Excel data file
OBIO similar filings
- 8 Jun 23 Bringing medical inn vation to life Bringing medical inn vation to life Orchestra BioMed Corporate Presentation Q2 2023
- 24 Mar 23 Index to Consolidated Financial Statements
- 13 Mar 23 Bringing medical inn vation to life Orchestra BioMed Corporate Presentation Q1 2023
- 31 Jan 23 Entry into a Material Definitive Agreement
- 25 Jan 23 Departure of Directors or Certain Officers
- 24 Jan 23 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
- 23 Jan 23 Other Events
Filing view
External links
Exhibit 16.1
January 31, 2023
Office of the Chief Accountant
Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
Ladies and Gentlemen:
We have read Orchestra Biomed Holdings, Inc.’s (formerly known as Health Sciences Acquisitions Corporation 2) statements included under Item 4.01 of its Form 8-K dated January 25, 2023. We agree with the statements concerning our Firm under Item 4.01, in which we were informed of our dismissal on January 26, 2023. We are not in a position to agree or disagree with other statements contained therein.
Very truly yours,
/s/ WithumSmith + Brown, PC | |
WithumSmith+Brown, PC |
New York, New York